Statement of Changes in Beneficial Ownership (4)
March 22 2023 - 4:50PM
Edgar (US Regulatory)
FORM 4
☐
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Silva Francisco |
2. Issuer Name and Ticker or Trading Symbol
BioRestorative Therapies, Inc.
[
BRTX
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner __X__ Officer (give title below) _____ Other (specify below) VP of Research and Development |
(Last)
(First)
(Middle)
40 MARCUS DRIVE |
3. Date of Earliest Transaction
(MM/DD/YYYY)
3/20/2023 |
(Street)
MELVILLE, NY 11747 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
(City)
(State)
(Zip)
|
Rule 10b5-1(c) Transaction Indication
☐
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to
satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 3/20/2023 | | F(1) | | 6729 | D | $2.92 | 158943 (2) | D | |
Common Stock | | | | | | | | 12136 | I | IRA |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option | $3000 | | | | | | | (3) | 10/4/2023 | Common Stock | 1 | | 1 | D | |
Stock Option | $3000 | | | | | | | (3) | 2/18/2024 | Common Stock | 3 | | 3 | D | |
Stock Option | $3000 | | | | | | | 3/12/2014 | 3/11/2024 | Common Stock | 1 | | 1 | D | |
Stock Option | $3000 | | | | | | | (3) | 10/23/2024 | Common Stock | 9 | | 9 | D | |
Stock Option | $3000 | | | | | | | (3) | 9/4/2025 | Common Stock | 6 | | 6 | D | |
Stock Option | $3000 | | | | | | | (3) | 6/10/2026 | Common Stock | 15 | | 15 | D | |
Stock Option | $3000 | | | | | | | (3) | 7/12/2027 | Common Stock | 20 | | 20 | D | |
Stock Option | $3000 | | | | | | | (3) | 10/29/2028 | Common Stock | 25 | | 25 | D | |
Stock Option | $5.08 | | | | | | | (4) | 3/18/2031 | Common Stock | 293479 | | 293479 | D | |
Stock Option | $5.08 | | | | | | | (5) | 11/4/2031 | Common Stock | 42059 | | 42059 | D | |
Stock Option | $2.91 | | | | | | | (6) | 2/17/2033 | Common Stock | 106762 | | 106762 | D | |
Explanation of Responses: |
(1) | Shares were withheld from vested stock grant to pay the associated withholding taxes. |
(2) | Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024. |
(3) | The option is currently exercisable. |
(4) | The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested. |
(5) | The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 and 21,029 shares in eight nearly equal quarterly installments beginning on November 4, 2022 and continuing every three months thereafter until fully vested. |
(6) | The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Silva Francisco 40 MARCUS DRIVE MELVILLE, NY 11747 | X | X | VP of Research and Development |
|
Signatures
|
/s/ Francisco Silva | | 3/21/2023 |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
BioRestorative Therapies (NASDAQ:BRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioRestorative Therapies (NASDAQ:BRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024